Aquaporin raised $24.77 million in a 2024 rights issue to reach break-even within two to three years, funding the scale-up of its biomimetic membranes. The Danish company embeds the aquaporin protein as an additive that powers both forward osmosis and reverse osmosis modules, selling point-of-use purifiers, brackish-water elements, and industrial systems.
Wanna find more about one of the water sector’s Rockstars? Let’s explore Aquaporin’s path:
with 🎙️ Matt Boczkowski – CEO at Aquaporin